Alison Bateman-House, PhD, MPH, MA is an assistant professor in the Division of Medical Ethics at NYU Langone Health’s School of Medicine. She is co-chair of the Working Group on Compassionate Use and Preapproval Access (CUPA), an academic group that studies ethical issues concerning access to investigational medical products and which is composed of patient advocates, clinicians, members of industry, former FDA staffers, lawyers, and academics. She is also co-chair of Pediatric Gene Therapy and Medical Ethics (PGTME), an interdisciplinary working group examining ethical issues in gene therapy clinical trials involving children with life-limiting conditions. Bateman-House also serves as the non-voting, non-paid chair of the NYU/Janssen Pharmaceutical Compassionate Use Advisory Committees (CompACs) for Infectious Diseases and NeuroPsychology. She has published and spoken extensively on how to best handle requests for trial and non-trial access to investigational drugs and on related ethical issues. She has also written and spoken frequently on the history and ethics of using humans as research subjects and on clinical trial accessibility.